CRP and autoimmune disease: While direct evidence for the impact of MLLT10 on autoimmune diseases has not been established, studies indicated a close association with C-reactive protein levels [85], widely recognized as a valuable indicator of disease activity in various autoimmune rheumatic diseases [86].